Discontinued — last reported Q3 '25
Operating Lease Liability - Undiscounted Excess Amount
West Pharmaceutical Services Operating Lease Liability - Undiscounted Excess Amount increased by 124.2% to $26.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 105.3%, from $13.10M to $26.90M. Over 3 years (FY 2020 to FY 2023), Operating Lease Liability - Undiscounted Excess Amount shows relatively stable performance with a 2.7% CAGR.
Analysis
How to read this metric
Changes reflect shifts in the discount rates used for lease accounting or changes in the duration of the lease portfolio.
Detailed definition
This represents the difference between the total undiscounted future lease payments and the present value of those payme...
Peer comparison
Used by analysts to reconcile lease accounting differences between companies with varying discount rate assumptions.
operating_lease_liability_undiscounted_excessHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.30M | $12.60M | $14.10M | $15.00M | $14.70M | $13.90M | $17.70M | $17.10M | $16.40M | $16.00M | $15.90M | $15.30M | $15.00M | $14.20M | $13.10M | $12.80M | $12.00M | $26.90M |
| QoQ Change | — | -5.3% | +11.9% | +6.4% | -2.0% | -5.4% | +27.3% | -3.4% | -4.1% | -2.4% | -0.6% | -3.8% | -2.0% | -5.3% | -7.7% | -2.3% | -6.3% | +124.2% |
| YoY Change | — | — | — | — | +10.5% | +10.3% | +25.5% | +14.0% | +11.6% | +15.1% | -10.2% | -10.5% | -8.5% | -11.3% | -14.4% | -14.7% | -15.5% | +105.3% |
Operating Lease Liability - Undiscounted Excess Amount at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating lease liability - undiscounted excess amount?
- West Pharmaceutical Services (WST) reported operating lease liability - undiscounted excess amount of $26.90M in Q1 2026.
- How has West Pharmaceutical Services's operating lease liability - undiscounted excess amount changed year-over-year?
- West Pharmaceutical Services's operating lease liability - undiscounted excess amount increased by 105.3% year-over-year, from $13.10M to $26.90M.
- What is the long-term trend for West Pharmaceutical Services's operating lease liability - undiscounted excess amount?
- Over 3 years (2020 to 2023), West Pharmaceutical Services's operating lease liability - undiscounted excess amount has grown at a 2.7% compound annual growth rate (CAGR), from $14.70M to $15.90M.
- What does operating lease liability - undiscounted excess amount mean?
- The difference between the total future lease payments and their current value on the balance sheet.